News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
716,659 Results
Type
Article (41202)
Company Profile (272)
Press Release (675185)
Multimedia
Podcasts (55)
Webinars (12)
Section
Business (209705)
Career Advice (2177)
Deals (36216)
Drug Delivery (106)
Drug Development (81432)
Employer Resources (175)
FDA (16411)
Job Trends (15372)
News (352928)
Policy (33481)
Tag
2024 BioCapital Digital (7)
2024 BioForest Digital (3)
2024 BioForest Standard (1)
2024 BioMidwest Digital (8)
2024 BioMidwest Standard (2)
2024 Bio NC Digital (5)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (18)
2024 Biotech Beach Digital (8)
2024 Biotech Beach Standard (5)
2024 Genetown Digital (5)
2024 Genetown Standard (10)
2024 Lone Star Bio Digital (6)
2024 Pharm Country Digital (6)
2024 Pharm Country Standard (4)
2025 BioForest Digital (1)
2025 Lone Star Bio Digital (5)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (2)
2026 Bio NC Standard (1)
2026 Biotech Bay Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (2)
2026 Genetown Elite (3)
2026 Genetown Standard (1)
2026 Pharm Country Elite (1)
2026 Pharm Country Standard (2)
Academia (2648)
Accelerated approval (5)
Adcomms (21)
Allergies (88)
Alliances (51351)
ALS (88)
Alzheimer's disease (1400)
Antibody-drug conjugate (ADC) (127)
Approvals (16410)
Artificial intelligence (260)
Autoimmune disease (21)
Automation (16)
Bankruptcy (367)
Best Places to Work (12015)
BIOSECURE Act (20)
Biosimilars (108)
Biotechnology (184)
Bladder cancer (77)
Brain cancer (27)
Breast cancer (280)
Cancer (2266)
Cardiovascular disease (178)
Career advice (1825)
Career pathing (30)
CAR-T (152)
Cell therapy (435)
Cervical cancer (19)
Clinical research (66221)
Collaboration (848)
Compensation (540)
Complete response letters (21)
COVID-19 (2644)
CRISPR (41)
C-suite (247)
Cystic fibrosis (100)
Data (2200)
Decentralized trials (2)
Denatured (19)
Depression (43)
Diabetes (269)
Diagnostics (6549)
Digital health (18)
Diversity (8)
Diversity, equity & inclusion (45)
Drug discovery (123)
Drug pricing (110)
Drug shortages (26)
Duchenne muscular dystrophy (93)
Earnings (87584)
Editorial (41)
Employer branding (21)
Employer resources (149)
Events (114992)
Executive appointments (745)
FDA (17675)
Featured Employer (50)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (758)
Gene editing (106)
Generative AI (19)
Gene therapy (310)
GLP-1 (718)
Government (4633)
Grass and pollen (5)
Guidances (59)
Healthcare (19589)
Huntington's disease (23)
IgA nephropathy (27)
Immunology and inflammation (116)
Indications (29)
Infectious disease (2793)
Inflammatory bowel disease (138)
Inflation Reduction Act (8)
Influenza (53)
Intellectual property (96)
Interviews (346)
IPO (16728)
IRA (44)
Job creations (3774)
Job search strategy (1541)
Kidney cancer (10)
Labor market (38)
Layoffs (477)
Leadership (18)
Legal (8120)
Liver cancer (75)
Lung cancer (321)
Lymphoma (153)
Machine learning (7)
Management (60)
Manufacturing (319)
MASH (68)
Medical device (13727)
Medtech (13732)
Mergers & acquisitions (20039)
Metabolic disorders (688)
Multiple sclerosis (81)
NASH (16)
Neurodegenerative disease (89)
Neuropsychiatric disorders (27)
Neuroscience (1938)
NextGen: Class of 2025 (6841)
Non-profit (4748)
Northern California (2674)
Now hiring (39)
Obesity (365)
Opinion (217)
Ovarian cancer (75)
Pain (85)
Pancreatic cancer (85)
Parkinson's disease (150)
Partnered (21)
Patents (236)
Patient recruitment (111)
Peanut (48)
People (59244)
Pharmaceutical (65)
Pharmacy benefit managers (19)
Phase I (20628)
Phase II (29155)
Phase III (21718)
Pipeline (1193)
Policy (148)
Postmarket research (2584)
Preclinical (8784)
Press Release (70)
Prostate cancer (107)
Psychedelics (32)
Radiopharmaceuticals (251)
Rare diseases (385)
Real estate (6245)
Recruiting (65)
Regulatory (22844)
Reports (46)
Research institute (2409)
Resumes & cover letters (370)
Rett syndrome (5)
RNA editing (5)
RSV (42)
Schizophrenia (69)
Series A (131)
Series B (85)
Service/supplier (18)
Sickle cell disease (54)
Southern California (2301)
Special edition (14)
Spinal muscular atrophy (148)
Sponsored (33)
Startups (3657)
State (2)
Stomach cancer (13)
Supply chain (70)
Tariffs (40)
The Weekly (34)
United States (23347)
Vaccines (703)
Venture capitalists (41)
Weight loss (238)
Women's health (36)
Worklife (19)
Date
Today (145)
Last 7 days (886)
Last 30 days (2652)
Last 365 days (33343)
2025 (10759)
2024 (35722)
2023 (40632)
2022 (51792)
2021 (56499)
2020 (55286)
2019 (48362)
2018 (36535)
2017 (32919)
2016 (32462)
2015 (38550)
2014 (32138)
2013 (27178)
2012 (29472)
2011 (30161)
2010 (28089)
Location
Africa (759)
Alabama (53)
Alaska (7)
Arizona (239)
Arkansas (14)
Asia (38940)
Australia (6375)
California (6128)
Canada (2026)
China (524)
Colorado (269)
Connecticut (275)
Delaware (150)
Europe (84977)
Florida (922)
Georgia (208)
Hawaii (1)
Idaho (61)
Illinois (561)
India (27)
Indiana (310)
Iowa (11)
Japan (162)
Kansas (105)
Kentucky (25)
Louisiana (11)
Maine (62)
Maryland (913)
Massachusetts (4602)
Michigan (224)
Minnesota (395)
Mississippi (2)
Missouri (84)
Montana (28)
Nebraska (25)
Nevada (64)
New Hampshire (64)
New Jersey (1740)
New Mexico (29)
New York (1752)
North Carolina (1020)
North Dakota (8)
Northern California (2674)
Ohio (213)
Oklahoma (15)
Oregon (36)
Pennsylvania (1383)
Puerto Rico (12)
Rhode Island (33)
South America (1151)
South Carolina (22)
South Dakota (1)
Southern California (2301)
Tennessee (103)
Texas (915)
Utah (184)
Virginia (148)
Washington D.C. (65)
Washington State (556)
West Virginia (3)
Wisconsin (53)
716,659 Results for "pace analytical services inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
FDA Clearance and First in Human Use for SoloPace™ Temporary Pacing System for TAVR
April 17, 2025
·
1 min read
Press Releases
Abbott Highlights New AVEIR™ Data, Initiates Trial for the Company’s Conduction System Pacing Technology
April 28, 2025
·
4 min read
Press Releases
Araceli Biosciences Closes $11.2M Seed Financing to Change the Pace of Drug Discovery
April 24, 2025
·
2 min read
Press Releases
BriaCell Enrollment Pace Accelerating in Phase 3 Clinical Study in Advanced Metastatic Breast Cancer (Bria-ABC)
April 22, 2025
·
5 min read
Press Releases
FDA Approves WiSE® System, World’s First and Only Leadless Left Ventricular Endocardial Pacing (LVEP) Device for CRT
April 17, 2025
·
3 min read
Press Releases
Lupus Research Alliance Grants Lupus Innovation Awards to Eleven Talented Researchers to Accelerate Pace of Discovery in Lupus Research
April 16, 2025
·
7 min read
Press Releases
Aplos Analytics Expands Cloud-Based Platform to Include Custom Outputs
April 23, 2025
·
1 min read
Cardiovascular disease
Silence Quiets Phase III Pace for Lipoprotein Drug, Seeks Partner
The search for a partner for zerlasiran is ongoing, according to Silence. In the meantime, the biotech will focus its resources on divesiran, which it is testing for polycythemia vera and other hematologic indications.
February 28, 2025
·
2 min read
·
Tristan Manalac
Business
Navigate BioPharma Services, Inc. in Collaboration with Partners Validate Analytical Assay for Acute Myeloid Leukemia Measurable Residual Disease (AML-MRD) Assessment
Navigate BioPharma Services, Inc. in Collaboration with Partners Validate Analytical Assay for Acute Myeloid Leukemia Measurable Residual Disease (AML-MRD) Assessment.
March 15, 2024
·
3 min read
Eurofins CDMO Alphora Inc. Announces the Launch of Expanded Drug Product Analytical Laboratory
Eurofins CDMO Alphora Inc., a global Contract Development & Manufacturing Organization and part of the international network of Eurofins laboratories, is pleased to announce a significant expansion of its Drug Product Analytical Services Laboratory, increasing its footprint three-fold.
May 29, 2024
·
2 min read
1 of 71,666
Next
